Heart Disease News and Research

Latest Heart Disease News and Research

Scientists receive $1.4 million NSF grant to develop robotic device for heart surgery

In a truly interdisciplinary effort, a team of biomedical scientists and engineers from the University of Houston and physicians from The Methodist Hospital Research Institute are collaborating to develop a platform for image-guided and robot-assisted surgeries on beating hearts that is minimally invasive.

17 Dec 2010

FDA recommends removal of breast cancer indication from Avastin label

The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.

17 Dec 2010

Study: Natural high hemoglobin levels safe for kidney disease patients on dialysis

Naturally occurring high hemoglobin levels are safe for kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

17 Dec 2010

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Researchers at Children's Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls.

16 Dec 2010

Omega-3 EPA or combination of EPA and DHA provide clear antidepressant benefits

Researchers at the University of Illinois at Chicago completed a review of previously published research on antidepressant benefits of Omega-3 essential fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The review comprised a meta-analysis of 15 randomized, double-blind, placebo-controlled studies in patients with depression and results were presented at the recent annual meeting of the American College of Neuropsychopharmacology.

16 Dec 2010

Amarin completes patient randomization in AMR101 Phase 3 trial in patients with high triglyceride levels

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported the completion of patient randomization for its ANCHOR trial, a pivotal Phase 3 trial of AMR101. The Company indicated that it anticipates reporting top-line results from this trial in Q2 2011.

16 Dec 2010

Second brain death exam impacts organ donation rates

Requiring a second exam on a person who is considered brain dead may be unnecessary, according to a study on the impact of a second brain death exam on organ donation rates. The research is published in the December 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

16 Dec 2010

Determinants of health have stronger impact on Canadians' health than healthy lifestyle

A report released today by the Health Council of Canada declares that unless governments change their approach to addressing the needs of poorer and socially disadvantaged Canadians, we are destined to continue to spend large amount of dollars on our health care system. Governments must expand their approach to health promotion in order to tackle the major societal factors that lead to poor health and to take pressure off health care budgets.

16 Dec 2010

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

Miracor Medical Systems GmbH announced today that the company has received CE-mark for the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI).

16 Dec 2010

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.

16 Dec 2010

UT Southwestern and Rabin Medical Center enter innovative 5-year affiliation agreement

UT Southwestern Medical Center and Rabin Medical Center, Israel, two of the world's top academic medical centers, announced today that they have entered into an innovative affiliation agreement for the next five years.

16 Dec 2010

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

Scientists from deCODE genetics and academic colleagues from Iceland, the UK, US, Netherlands, Spain and Romania today report the discovery of a set of single-letter variations in the sequence of the human genome that impact individual baseline levels of prostate specific antigen, or PSA.

16 Dec 2010

Study finds no association between vitamin D and parathyroid hormone levels in cardiovascular mortality of older adults

According to New Study Published in The American Journal of Medicine, there is burgeoning public interest in possible wide-ranging health benefits from vitamin D, including cardiovascular health.

16 Dec 2010

SBUMC to unveil one-of-a-kind neuroendovascular simulator

Stony Brook University Medical Center will unveil this Friday a one-of-a-kind neuroendovascular simulator that recreates vasculature in the brain, including scenarios of damaged vessels from acute stroke, brain aneurysms, and other cerebrovascular anomalies. Affectionately known in the lab as "Headley".

16 Dec 2010

Systematic study on protein-protein interfaces explain "promiscuous" phenomena of its binding

Interactions between proteins are at the heart of cellular processes, and those interactions depend on the interfaces where the direct physical contact occurs. A new study published this week suggests that there may be roughly a thousand structurally-distinct protein-protein interfaces - and that their structures depend largely on the simple physics of the proteins.

16 Dec 2010

Use of vitamin K antagonists is driven by availability of oral formulation

Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that, in the treatment of atrial fibrillation, surveyed European cardiologists indicate that use of vitamin K antagonists, as a class, is primarily driven by the availability of an oral formulation, overall low cost and widespread inclusion on European medical society guidelines and hospital formularies.

16 Dec 2010

Study finds occurrence of infection following surgical procedures

Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.

16 Dec 2010

Nation's leading health care systems collaborate to improve quality while reducing costs

Six of the nation's leading health care systems today announced a first-of-its-kind collaboration to improve health care quality while reducing costs.

16 Dec 2010

PEG-Prom encased nanoparticle aids in cancer detection and treatment

In a proof of principal study in mice, scientists at Johns Hopkins and the Virginia Commonwealth University have shown that a set of genetic instructions encased in a nanoparticle can be used as an "ignition switch" to rev up gene activity that aids cancer detection and treatment.

16 Dec 2010

Almonds can help treat, prevent type 2 diabetes and cardiovascular disease

With nearly 16 million Americans living today with pre-diabetes, a condition that is the precursor to type 2 diabetes, and half of all Americans expected to have some form of diabetes by the year 2020, healthy eating is more important than ever. But here is some good news: a recent scientific study shows that incorporating almonds into your diet can help treat and possibly prevent type 2 diabetes, as well as cardiovascular disease.

15 Dec 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Scientists receive $1.4 million NSF grant to develop robotic device for heart surgery

FDA recommends removal of breast cancer indication from Avastin label

Study: Natural high hemoglobin levels safe for kidney disease patients on dialysis

Researchers begin placebo-controlled trial to test drug treatment for Rett syndrome

Omega-3 EPA or combination of EPA and DHA provide clear antidepressant benefits

Amarin completes patient randomization in AMR101 Phase 3 trial in patients with high triglyceride levels

Second brain death exam impacts organ donation rates

Determinants of health have stronger impact on Canadians' health than healthy lifestyle

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

UT Southwestern and Rabin Medical Center enter innovative 5-year affiliation agreement

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

Study finds no association between vitamin D and parathyroid hormone levels in cardiovascular mortality of older adults

SBUMC to unveil one-of-a-kind neuroendovascular simulator

Systematic study on protein-protein interfaces explain "promiscuous" phenomena of its binding

Use of vitamin K antagonists is driven by availability of oral formulation

Study finds occurrence of infection following surgical procedures

Nation's leading health care systems collaborate to improve quality while reducing costs

PEG-Prom encased nanoparticle aids in cancer detection and treatment

Almonds can help treat, prevent type 2 diabetes and cardiovascular disease

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in